询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
L-Cystine diethyl ester | CAS:583-89-1
L-Cystine diethyl ester
  • 名称:L-胱氨酸二乙酯 | L-Cystine diethyl ester
  • CAS号:583-89-1
  • 别名:
  • 分子式:C10H20N2O4S2
  • 分子量:296.41
  • EINESC号:

产品描述

物理化学性质

密度 1.252±0.06 g/cm3 (20 º

安全数据

没有数据没有数据

SDS

来源 SDS样本
没有数据没有数据
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Comparison of SSI with APCI as an interface of HPLC-mass spectrometry for analysis of a drug and its metabolites.Tetsuya Arinobu et al.Journal of the American Society for Mass Spectrometry, 13(3), 204-208 (2002-03-23) In-vitro characterization of the cytochrome P450 isoenzymes involved in the back oxidation and N-dealkylation of reduced haloperidol.L P Pan et al.Pharmacogenetics, 8(5), 383-389 (1998-11-24) Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.José M Entrena et al.Psychopharmacology, 205(1), 21-33 (2009-03-28) Salt formation in solid dispersions consisting of polyacrylic acid as a carrier and three basic model compounds resulting in very high glass transition temperatures and constant dissolution properties upon storage.Ilse Weuts et al.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 25(4-5), 387-393 (2005-05-17) Determination of 4-(4-chlorophenyl)-4-hydroxypiperidine, a metabolite of haloperidol, by gas chromatography with electron-capture detection.J Fang et al.Journal of chromatography. B, Biomedical applications, 682(2), 283-288 (1996-07-12) [Chemical toxicological analysis of haloperidol metabolite 4-(4-chlorophenyl)-4-hydroxypipiridine in urine by high-performance liquid chromatography].A B Skorniakova et al.Sudebno-meditsinskaia ekspertiza, 52(1), 45-48 (2009-04-18) Sensitive determination of 4-(4-chlorophenyl)-4-hydroxypiperidine, a metabolite of haloperidol, in a rat biological sample by HPLC with fluorescence detection after pre-column derivatization using 4-fluoro-7-nitro-2,1,3-benzoxadiazole.Yasuhiko Higashi et al.Biomedical chromatography : BMC, 20(9), 964-970 (2006-03-01)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交